FCER1A and asthma: In asthma patients at baseline, the percentage of type II cDCs expressing FcεRIα (72.3 (66.4, 80.8) was significantly higher compared to the percentage of type I cDCs (21.65 [16.28, 24.9]) (p = .0002) and pDCs (23.6 [14.08, 25.3]) (p = .0002) expressing the receptor (Figure 6A).